Smith & Nephew PLC (SNl)

"Smith & Nephew PLC stock price live, this page displays LON SN stock exchange data. View the SN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Smith & Nephew PLC real time stock price chart below.

What Is the Smith & Nephew PLC Stock Price Today?
The Smith & Nephew PLC stock price today is 977.60.

What Is the Stock Symbol for Smith & Nephew PLC?
The stock symbol for Smith & Nephew PLC is ""SN.""

What Stock Exchange Does Smith & Nephew PLC Trade On?
Smith & Nephew PLC is listed and trades on the London stock exchange.

Is Smith & Nephew PLC a Good Stock to Buy?
Determining whether Smith & Nephew PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.

You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SN quote. (ISIN: GB0009223206)"

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.